Please try another search
For the six months ended 30 June 2016, Lifeline Scientific, Inc revenues increased 21% to $18.2M. Net income increased from $95K to $1.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Research and development decrease of 28% to $371K (expense), Loss from abandonment of intangibles decrease from $36K (expense) to $0K.
Period Ending: | Jun 30, 2016 | Dec 31, 2015 | Jun 30, 2015 | Dec 31, 2014 |
---|---|---|---|---|
Total Revenue | 18.19 | 24.37 | 15.02 | 20.11 |
Gross Profit | 11.44 | 14.77 | 8.95 | 12.24 |
Operating Income | 2.02 | 5.6 | 0.13 | 2.41 |
Net Income | 1.94 | 12.21 | 0.09 | 3.51 |
Period Ending: | Jun 30, 2016 | Dec 31, 2015 | Jun 30, 2015 | Dec 31, 2014 |
---|---|---|---|---|
Total Assets | 43.18 | 41.72 | 29.37 | 30.63 |
Total Liabilities | 5.78 | 6.3 | 6.12 | 7.37 |
Total Equity | 37.4 | 35.42 | 23.25 | 23.26 |
Period Ending: | Jun 30, 2016 | Dec 31, 2015 | Jun 30, 2015 | Dec 31, 2014 |
---|---|---|---|---|
Period Length: | 6 Months | 12 Months | 6 Months | 12 Months |
Cash From Operating Activities | 1.58 | 8.19 | 0.95 | 1.84 |
Cash From Investing Activities | -1 | -2.27 | -1.12 | -2.42 |
Cash From Financing Activities | -0.01 | -2.19 | -0 | 1.06 |
Net Change in Cash | 0.57 | 3.58 | -0.27 | 0.3 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review